Responding to the Opioid Addiction Epidemic
Dr. Andrew Kolodny is one of the nation’s leading experts on the prescription opioid and heroin crisis. He is co-director of the Opioid Policy Research Collaborative at the Heller School for Social Policy and Management at Brandeis University. He is also the executive director of Physicians for Responsible Opioid Prescribing, an organization with a mission to reduce morbidity and mortality caused by overprescribing of opioid analgesics.
Dr. Kolodny previously served as chief medical officer for Phoenix House, a national non-profit addiction treatment agency and chair of psychiatry at Maimonides Medical Center in New York City. Dr. Kolodny has a long-standing interest in public health. He began his career working for the New York City Department of Health and Mental Hygiene in the Office of the Executive Deputy Commissioner. For New York City, he helped develop and implement multiple programs to improve the health of New Yorkers and save lives, including citywide buprenorphine programs, Naloxone overdose prevention programs and emergency room-based screening, brief intervention and referral to treatment (SBIRT) programs for drug and alcohol misuse.
Northwell Health is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Northwell Health designates this live activity for a maximum of 1.5 AMA PRA Category 1 credits ™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Northwell Health adheres to the ACCME’s Standards for Commercial Support. Any individuals in a position to control the content of a CME activity, including faculty, planners, reviewers or others are required to disclose all relevant financial relationships with commercial interests. All relevant conflicts of interest will be resolved prior to the commencement of the activity.
Planner and Speaker’s Disclosures:
Harold Koplewicz, MD, Ron Steingard, MD, and John Q. Young, MD, have nothing to disclose. Andrew Kolodny, MD, has nothing to disclose.
Recognition of Program Support:
An announcement of program support will be made to all attendees at the beginning of each Regularly Scheduled Session.